Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts

Journal of Cardiovascular Pharmacology
W Linz, B A Schölkens

Abstract

To investigate the influence of local cardiac converting enzyme (CE) inhibition on the effects of angiotensin I (ANG I), ANG II, and bradykinin (BK), experiments were performed in ischemic isolated perfused working rat hearts. Acute regional myocardial ischemia was induced by 15 min occlusion of the left coronary artery followed by reperfusion. In ischemic isolated rat hearts, perfusion with ramiprilat (100 ng/ml, 2.58 x 10(-7) mol/l), the active moiety of the CE inhibitor ramipril, after coronary occlusion protected against ventricular fibrillation that invariably occurred in untreated control hearts in the reperfusion period. Addition of ANG I and ANG II to the perfusate enhanced, whereas BK reduced postischemic reperfusion arrhythmias, which were almost abolished in the hearts from ramipril (1 mg/kg p.o.) pretreated rats. Perfusion with ANG I and ANG II reduced cardiac function and coronary flow, increased the activities of lactate dehydrogenase and creatine kinase in the perfusate, and decreased high-energy-rich phosphates and glycogen in the myocardium. In contrast, BK reduced the enzymatic activities in the perfusate and improved the metabolic parameters in the myocardium. In hearts from ramipril pretreated animals, the A...Continue Reading

Citations

Oct 1, 1990·Cardiovascular Drugs and Therapy·C Linder, G Heusch
Jul 18, 1989·European Journal of Pharmacology·L Carlsson, T Abrahamsson
Apr 6, 1993·European Journal of Pharmacology·J C HartmanR J Shebuski
Dec 1, 1994·International Journal of Cardiology·Y H Zhang, S C Xu
Nov 5, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·K K Veeravalli, A Akula
Oct 7, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·K K VeeravalliM K Kota
Feb 1, 1993·British Journal of Pharmacology·R ChahineR Nadeau
Jan 1, 1989·Clinical and Experimental Hypertension. Part A, Theory and Practice·W LinzD Ganten
Jul 14, 2000·Journal of the American Geriatrics Society·I SlavachevskyM Ravid
Jun 1, 1994·Hypertension·H NollyA G Scicli
Jun 8, 2001·Journal of Cardiovascular Pharmacology·G Ertl, K Hu
Jul 31, 1998·Cardiovascular Research·M J DumoulinD Lamontagne
Apr 1, 1988·The Australian and New Zealand Journal of Surgery·G H White
Jan 1, 1988·Clinical and Experimental Hypertension. Part A, Theory and Practice·B A Schölkens, W Linz
Jun 1, 1990·Clinical Cardiology·W J McKenna, G A Haywood
Mar 1, 1991·Basic Research in Cardiology·R A TioH Wesseling
Mar 26, 2005·Canadian Journal of Physiology and Pharmacology·Marie-Josée DumoulinDaniel Lamontagne
Feb 9, 2000·American Journal of Physiology. Heart and Circulatory Physiology·Y H LiuO A Carretero
Aug 15, 2002·Cardiovascular Drug Reviews·Kazuyoshi Hosoya, Toshihiko Ishimitsu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.